The recent randomized Stroke Hyperglycemia Insulin Network Effort trial, which compared intensive glucose lowering with standard treatment in patients with stroke, found no difference in the death and favorable mRS score at 3 months [44]. The gene discussed is INS; the disease is stroke disorder.